Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Endoscopic Management of Patients With High Risk T1a and T1b N0M0 Esophageal Adenocarcinoma: a Prospective Multicenter Registry.

NCT03222635 is registered in ClinicalTrials.gov with Amsterdam UMC as lead sponsor.

NCT NCT03222635
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03222635 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Endoscopic Management of Patients With High Risk T1a and T1b N0M0 Esophageal Adenocarcinoma: a Prospective Multicenter Registry.
Lead sponsor
Amsterdam UMC
Phase
Not applicable
Overall status
Recruiting
Start date
July 25, 2017
Completion date
July 25, 2028
Enrollment
225 (estimated)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

barrett esophagus, high-risk mucosal esophageal adenocarcinoma, submucosal esophageal adenocarcinoma